VBL Therapeutics (also known as Notable Labs, נוטבל לאבס, בע"מ; formerly Vascular Biogenics) is a biopharmaceutical company focused on the development of treatments for cancer. It offers VB-111, a gene-based biologic agent for solid tumor indications for ovarian cancer, recurrent glioblastoma, colon cancer, and thyroid cancer.